Project Grant K99HL179245
- Federal Project Grant Summary The University of Texas at Austin received a $1,356,922 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 5, 2025, with completion targeted for May 31, 2029. The grant funds research to develop optimized novel leaflet biomaterials for replacement heart valves (RHV), addressing critical limitations in current bioprosthetic heart valve technology. The research...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $416,849 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 15, 2025, with completion targeted for May 31, 2029. The grant funds research to validate TAD1 (Transthyretin Amyloid Detection 1), a blood biomarker peptide probe designed to detect cardiac ATTR (Amyloidosis Transthyretin) amyloidosis. The...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Texas Southwestern Medical Center a $249,000 Project Grant (CFDA 93.837 – Cardiovascular Diseases Research) effective August 1, 2025, through June 30, 2028, to conduct research investigating the mechanisms of dyspnea on exertion (DOE) and exercise intolerance in patients with heart failure with preserved ejection fraction (HFpEF). The research will examine how obesity-related mechanical...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $691,556 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with completion targeted for May 31, 2029. This research initiative addresses early detection and quantification of cardiac amyloidosis in asymptomatic carriers of the V122I transthyretin (TTR) allele, a genetic variant virtually...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $1,040,966 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 15, 2025, with completion anticipated by May 31, 2029. This award supports the development of adeno-associated virus (AAV)-based delivery vectors designed to enable targeted gene therapy for atrioventricular block (AVB) and other...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $164,127.00 to the University of Texas Health Science Center at Houston under the Cardiovascular Diseases Research program (CFDA 93.837) for a project spanning September 15, 2025, through August 31, 2030. Dr. Murdock's research team will develop and deliver an artificial intelligence-based facial recognition tool designed to improve screening and early detection of heritable thoracic aortic...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $1.62M project grant awarded September 25, 2025, under the National Heart, Lung, and Blood Institute's (NHLBI) Cardiovascular Diseases Research program (CFDA 93.837). The research project, extending through June 30, 2027, will deliver comprehensive metabolomic and genomic analysis services to identify biological pathways linking metabolic dysfunction and ectopic adiposity to cardiac dysfunction and...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $739,466 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, through May 31, 2030. This award supports the development of precision Positron Emission Tomography (PET) attenuation correction technology for combined PET/Magnetic Resonance (MR) imaging of cardiac sarcoidosis. The research addresses...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $149,804 Project Grant awarded on July 27, 2025, by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award funds research into the structure, function, and drug treatment of the native cardiac sarcomere in hypertrophic cardiomyopathy (HCM), the most common genetic cardiovascular disorder. The research will employ...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $498,000 project grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 2, 2025, with completion by August 31, 2028. This award supports molecular and mechanistic research investigating the genetic and epigenetic determinants of atrial fibrillation (AF), the most common serious cardiac arrhythmia affecting...
The National Heart, Lung, and Blood Institute (NHLBI) awarded The University of Texas Southwestern Medical Center a $143,461 Project Grant (CFDA 93.837 – Cardiovascular Diseases Research) for the period of April 1, 2026 through March 31, 2028. The award supports high-resolution phenotyping research investigating the hemodynamic consequences of thoracic endovascular aortic repair (TEVAR) in adults with descending thoracic aortic aneurysm (TAA). The research will comprehensively assess how graft material stiffness affects aortic hemodynamics and end-organ function in the heart, brain, and kidneys at both rest and during exercise—an area lacking prior comprehensive investigation. The project deliverables include detailed hemodynamic and end-organ evaluations employing advanced assessment methodologies to measure pressure, wave reflections, pulsatility, and functional consequences following descending TAA repair. This research addresses a critical gap in understanding the long-term vascular and pathological remodeling consequences of TEVAR, with findings intended to inform clinical approaches to minimizing adverse end-organ effects associated with aortic graft placement. The work will be performed at UT Southwestern's Dallas, Texas facility and contributes to the NHLBI's mission of advancing prevention and treatment of cardiovascular diseases through clinical and translational research.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $143.5k | 3/27/26 |